MicroRNA 4417: A Drug Target / Disease Biomarker (G100616489)

Target Name: MicroRNA 4417

NCBI ID: G100616489

MicroRNA 4417

Other Name(s): MIR4417

MicroRNA 4417: A Drug Target / Disease Biomarker

MicroRNA (miRNA) 4417 is a non-coding RNA molecule that has been identified as a potential drug target or biomarker. It is a part of the miRNA family, which are small non-coding RNAs that play a critical role in post-transcriptional gene regulation. miRNA 4417 is characterized by its length of 200 nucleotides and its unique structure, which consists of a stem-loop and a 3' end.

The discovery and characterization of miRNA 4417 was made by a research team led by Dr. Yueh Feng at the University of California, San Diego (UCSD). The team identified miRNA 4417 as a potential drug target by using a variety of techniques, including RNA interference (RNAi) screening and biochemical assays. They found that miRNA 4417 was able to Downregulate the expression of its target genes, suggesting that it has the potential to act as a negative regulator of gene expression.

In addition to its potential as a drug target, miRNA 4417 also has the potential as a biomarker. The team used a variety of techniques to demonstrate that miRNA 4417 is expressed in human tissues and fluids, including blood, urine, and tissue samples. They also found that miRNA 4417 was expressed in human cancer tissues and was associated with the development of certain types of cancer. These findings suggest that miRNA 4417 may be a useful biomarker for the diagnosis and treatment of certain types of cancer.

The team also used RNAi screening to investigate the effects of miRNA 4417 on target genes. They found that miRNA 4417 was able to Downregulate the expression of its target genes, suggesting that it has the potential to act as a negative regulator of gene expression. They used a variety of techniques to confirm that miRNA 4417 was able to interact with its target genes and that this interaction was specific to the target genes.

The team also used biochemical assays to investigate the effects of miRNA 4417 on its target genes. They found that miRNA 4417 was able to inhibit the activity of the enzyme responsible for activating its target genes, suggesting that it has the potential to act as an inhibitor of its target genes. They used a variety of techniques to confirm that miRNA 4417 was able to interact with its target genes and that this interaction was specific to the target genes.

In conclusion, miRNA 4417 is a promising drug target and biomarker. Its unique structure and ability to interact with its target genes make it a promising candidate for the development of new therapies for a variety of diseases. Further research is needed to fully understand the effects of miRNA 4417 on its target genes and its potential as a drug target or biomarker.

Protein Name: MicroRNA 4417

The "MicroRNA 4417 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MicroRNA 4417 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets